WE SELL NOTHING✳EVERY CLAIM → A PRIMARY SOURCE✳UNKNOWN IS A REAL ANSWER✳NO PRODUCTS · NO PROTOCOLS · NO VENDORS✳WE SELL NOTHING✳EVERY CLAIM → A PRIMARY SOURCE✳UNKNOWN IS A REAL ANSWER✳
← All Claim Checks
Source record · FDA labeling and randomized trials · reviewed July 17, 2026

Same ingredient name is not the same as same drug product.

Misleading
The circulating claim

“Saxenda, Victoza, generics, compounded liraglutide, and online liraglutide vials are all basically interchangeable.”

What the source record says

A shared ingredient name does not erase differences in reference product, approved indication, labeling, strength, manufacturing controls, or product identity. Large trials establish outcomes for identified products and study conditions, not every vial bearing the word liraglutide.

Why the claim misleads

Ingredient identity is being used as a shortcut for product approval, manufacturing equivalence, and indication.

Correction

Same ingredient name is not the same as same drug product.

Primary sources
Current Saxenda labeling on DailyMedOpen source ↗Pi-Sunyer et al., 2015Open source ↗Liraglutide library entryOpen source ↗
What changed

Added the source-verified Claim Check to the structured claim/source/change registry.

What would change our answer

A well-controlled human study tied to the exact product, population, route, and claimed outcome could change the answer. Mechanism, anecdotes, or a different product cannot substitute for that evidence.

Version history · 1 entry
  1. v1 · 2026-07-17Initial structured record created from the reviewed Claim Check.Source ↗
Boundary: This check evaluates a public claim. It does not assess an individual product or person and is not treatment, dosing, sourcing, or legal advice.